EQR
59
5
DOW
34
4
ESS
64
4
TXT
52
4
DE
56
10
HST
58
18
L
64
2
GLW
46
4
CTAS
59
4
TROW
51
3
VNO
50
-9
AON
52
2
KLAC
43
4
AMG
52
2
AMGN
38
-6
TMO
47
3
NWL
50
6
KMX
64
6
V
66
6
GT
56
2
EQR
59
5
DOW
34
4
ESS
64
4
TXT
52
4
DE
56
10
HST
58
18
L
64
2
GLW
46
4
CTAS
59
4
TROW
51
3
VNO
50
-9
AON
52
2
KLAC
43
4
AMG
52
2
AMGN
38
-6
TMO
47
3
NWL
50
6
KMX
64
6
V
66
6
GT
56
2
Financhill
Back

Structure Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Sell
16

GPCR
Structure Therapeutics

Last Price:
30.10
Seasonality Move:
-11.15%
Sell
40

LLY
Eli Lilly and

Last Price:
749.91
Seasonality Move:
3.67%
Sell
16
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $30.10. The Score for GPCR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $749.92. The Score for LLY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $30.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $749.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.9 Sell
Relative Strength Index (14 RSI): 29.57 Sell
Chaikin Money Flow: -746574 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.51 - 40.09) Sell
Bollinger Bands (100): (35.63 - 41.33) Sell

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -37.76 Sell
Relative Strength Index (14 RSI): 32.45 Sell
Chaikin Money Flow: 2603304 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (767.47 - 887.61) Sell
Bollinger Bands (100): (822.35 - 941.55) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.06 Sell
20-day SMA: 36.96 Sell
50-day SMA: 38.95 Sell
200-day SMA: 39.82 Sell
8-day EMA: 33.62 Sell
20-day EMA: 36 Sell
50-day EMA: 37.78 Sell
200-day EMA: 39.23 Sell

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 765.42 Sell
20-day SMA: 808.04 Sell
50-day SMA: 868.82 Sell
200-day SMA: 834.81 Sell
8-day EMA: 763.14 Sell
20-day EMA: 801.26 Sell
50-day EMA: 845.99 Sell
200-day EMA: 811.74 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.44 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):